1 AS
patients were classified as (
a) moderate-severe (n=93; aortic
2 In this cohort, 25 (38%) of 65
patients were classified as being low-risk, and the probabili
3 The remaining NTM infected
patients were classified as colonized.
4 Thus, 12
patients were classified as complete responders (58% HCV, med
5 At baseline, 67 of 236 (28%) glaucoma
patients were classified as disabled based on NEI VFQ-25 resu
6 AD
patients were classified as either typical AD (n = 100), limb
7 Patients were classified as follows: group I, pulmonary arter
8 Patients were classified as having a VF defect in the inferio
9 Patients were classified as having a wound complication or no
10 Patients were classified as having an adverse health event if
11 Patients were classified as having bacterial (n = 22), viral
12 Patients were classified as having CLAD on the basis of spiro
13 According to histopathologic findings,
patients were classified as having dilated cardiomyopathy (n=
14 After treatment,
patients were classified as having disease recurrence if cult
15 Patients were classified as having early (recent-onset) MS if
16 et representing 44 centers in the United States and Europe,
patients were classified as having had CED or a combined end
17 The remaining 1350 (62.3%)
patients were classified as having HFrEF.
18 Enrolled
patients were classified as having low transfusion burden, de
19 Patients were classified as having mild disease if they never
20 Patients were classified as having one of four patterns (patt
21 Patients were classified as having paroxysmal or persistent A
22 ed as having CD according to the new ESPGHAN guidelines, 43
patients were classified as having potential CD.
23 Patients were classified as having received "aggressive regim
24 Patients were classified as having severe mental illness if a
25 Using intra-individual coefficients of variation (CV%),
patients were classified as having stable (CV% <85th percenti
26 Patients were classified as having suspected, probable, or co
27 Patients were classified as having symptomatic or asymptomati
28 Patients were classified as having THV thrombosis if there wa
29 Using multimodal imaging, 197
patients were classified as having typical cCSC, 52 patients
30 Patients were classified as HER2-positive (HER2+) or -negativ
31 y rate, high GRACE score, or presence of diabetes mellitus,
patients were classified as high or low risk on the basis of
32 of the KIT D816V expressed allele burden (EAB) at month 6,
patients were classified as KIT responders (>/=25%, n = 17) o
33 Patients were classified as luminal A (n = 265), luminal B (n
34 All
patients were classified as N0 after RP.
35 Patients were classified as nonlocalized when preoperative im
36 Patients were classified as "
perfect reporters" (self-report
37 Cardiac resynchronization therapy defibrillator
patients were classified as permanent (daily mean AF burden >
38 Patients were classified as phenotype-positive (n=72) or phen
39 Thirty-three
patients were classified as progressive encephalomyelitis wit
40 At week 12,
patients were classified as responders (by either achieving l
41 Thirty-three
patients were classified as responders after 12 weeks of anti
42 Response was assessed after 12 weeks and
patients were classified as responders or non-responders acco
43 Patients were classified as responders to treatment (>/=50% d
44 According to surgical outcome,
patients were classified as seizure-free (SF, n = 14) or non-
45 Patients were classified as smoking on the day of surgery if
46 Patients were classified as "
target mismatch" if they had a s
47 Thirteen
patients were classified as unfavorable cases based on anatom
48 Patients were classified as using an active or avoidant illne
49 At baseline, 26
patients were classified as VMA+ and 98 patients were classif
50 At baseline, 26 patients were classified as VMA+ and 98
patients were classified as VMA-.